Avanos Medical, Inc. Common Stock (AVNS)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — May 19, 2026Investment Snapshot
- P/B of 1.48 — trading near book value
- Piotroski F-Score 6/9 — moderate financial health
- Loss-making — negative ROE of -8.5%
Avanos Medical, Inc. Common Stock (AVNS) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NYSE , with a market capitalisation of $1.2 billion . Key value metrics: P/B ratio 1.48, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Avanos Medical, Inc. Common Stock — Fundamental Analysis Summary
On financial health, AVNS shows a moderate Piotroski F-Score of 6/9, and negative return on equity of -8.5% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.11.
StockPik's composite Value Score for AVNS is 77/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
AVNS reports a solid gross margin of 51.5% (sector average: 40.1%) and a negative operating margin of -7.9%.
AVNS shows revenue growing at 2% year-over-year, with earnings growing at 81%.